Skip to main content
. 2021 Dec 16;12:778204. doi: 10.3389/fimmu.2021.778204

Figure 3.

Figure 3

Longitudinal assessment of IFNAR1, IFNAR2, sIFNAR2 and MxA gene expression. RNA relative expression of IFNAR1, IFNAR2, sIFNAR2 and MxA in PBMC from MS patients before and after 6 months of IFN-β therapy onset (N=41), assessed by real time-PCR using GAPDH as raeference gene. Significant p-values are shown with asterisk.